Clinical Endocrinology

PPAR and metabolism: insights from the study of human genetic variants
pp. 267-277(11)
Author: Gurnell M.

Tall stories: the devilish detail of genetic association studies
pp. 278-279(2)
Authors: Ellis J.A.; Harrap S.B.

Thyroid hormones and fetal brain development
pp. 280-281(2)
Author: Kilby M.D.

Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study
pp. 282-288(7)
Authors: Pop V.J.; Brouwers E.P.; Vader H.L.; Vulsma T.; van Baar A.L.; de Vijlder J.J.

Insulin resistance and -cell dysfunction in normoglycaemic European women with a history of gestational diabetes
pp. 289-297(9)
Authors: Kousta E.; Lawrence N.J.; Godsland I.F.; Penny A.; Anyaoku V.; Millauer B.A.; Cela E.; Johnston D.G.; Robinson S.; McCarthy M.I.

Epidemiological survey of thyroid volume and iodine intake in schoolchildren, postpartum women and neonates living in Ulaan Baatar
pp. 298-306(9)
Authors: Fuse Y.; Igari T.; Yamada C.; Sakano S.; Ito H.; Umenai T.; Irie M.

Usefulness of the free -subunit to diagnose hypogonadotropic hypogonadism
pp. 307-313(7)
Authors: Mainieri A.S.; Elnecave R.H.

Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans
pp. 314-320(7)
Authors: Giordano R.; Grottoli S.; Brossa P.; Pellegrino M.; Destefanis S.; Lanfranco F.; Gianotti L.; Ghigo E.; Arvat E.

Peripheral parameters of oxidative stress in Graves’ disease: the effects of methimazole and 131 iodine treatments
pp. 321-327(7)
Authors: Abalovich M.; Llesuy S.; Gutierrez S.; Repetto M.

Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor
pp. 328-338(11)
Authors: Kola B.; Korbonits M.; Diaz-Cano S.; Kaltsas G.; Morris D.G.; Jordan S.; Metherell L.; Powell M.; Czirják S.; Arnaldi G.; Bustin S.; Boscaro M.; Mantero F.; Grossman A.B.

Clinical and radiological features of patients with macroprolactinaemia
pp. 339-346(8)
Authors: Strachan M.W.J.; Teoh W.L.; Don-Wauchope A.C.; Seth J.; Stoddart M.; Beckett G.J.

Changes in both size and cytological features of thyroid nodule after levothyroxine treatment
pp. 347-353(7)
Authors: Vermiglio F.; Lo Presti V.P.; Violi M.A.; Moleti M.; Castagna M.G.; Finocchiaro M.D.; Mattina F.; Mandolfino M.; Zimbaro G.; Trimarchi F.

Increased expression of endothelin-1 and its mitogenic receptor ET_A in human papillary thyroid carcinoma
pp. 354-360(7)
Authors: Donckier J.E.; Michel L.; Van Beneden R.; Delos M.; Havaux X.

Accuracy of ultrasonography to establish the diagnosis and aetiology of permanent primary congenital hypothyroidism
pp. 361-365(5)
Authors: Kreisner E.; Camargo-Neto E.; Maia C.R.; Gross J.L.

An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood
pp. 366-373(8)
Authors: Ben-Shlomo Y.; Holly J.; McCarthy A.; Savage P.; Davies D.; Gunnell D.; Davey Smith G.

Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables
pp. 374-379(6)
Authors: Tassone F.; Lanfranco F.; Gianotti L.; Pivetti S.; Navone F.; Rossetto R.; Grottoli S.; Gai V.; Ghigo E.; Maccario M.

The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency
pp. 380-387(8)
Authors: Suliman A.M.; Freaney R.; Smith T.P.; McBrinn Y.; Murray B.; McKenna T.J.

Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves’ ophthalmopathy receiving corticosteroid therapy
pp. 388-395(8)
Authors: De Bellis A.; Bizzarro A.; Conte M.; Coronella C.; Solimeno S.; Perrino S.; Sansone D.; Guaglione M.; Wall J.R.; Bellastella A.

Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease
pp. 396-401(6)
Authors: Strieder T.G.A.; Prummel M.F.; Tijssen J.G.P.; Endert E.; Wiersinga W.M.

Hypoglycaemia in a patient with a gastrointestinal stromal tumour
pp. 402-404(3)
Authors: Beckers M.M.J.; Slee P.H.T.J.; van Doorn J.

PET scan in occult ectopic ACTH syndrome: a useful tool?
pp. 404-405(2)
Authors: Biering H.; Pirlich M.; Bauditz J.; Sandrock D.; Lochs H.; Gerl H.

Cortisol and the metabolic syndrome in South Indians
pp. 405-406(2)
Author: Syed A.A.

A survey of dopamine agonist withdrawal policy in UK endocrinologists treating patients with prolactinomas. Clinical Endocrinology 58, 111
pp. 406-406(1)
Authors: Wass J.; Turner H.

Presence of magnetic resonance imaging abnormalities of the hypothalamic–pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency
pp. 407-407(1)
Authors: Zenaty D.; Garel C.; Limoni C.; Czernichow P.; Léger J.